Abstract
A number of new octahydro-2H-chromene acetamide derivatives based on the monoterpenoid (−)-isopulegol were synthesized using a one-pot three-component Prins—Ritter reaction. The structure of the target compounds was determined using 1H and 13C NMR spectroscopy, high resolution mass spectrometry, and X-ray diffraction analysis. Most of the products exhibited high analgesic activity in in vivo tests. The highest analgesic activity was found for spirocyclic compound (4S)-2d, the effect of which is apparently mediated through the dopamine system. It was shown that compound (4S)-2d has a low acute toxicity.
References
I. Melnikova, Nat. Rev. DrugDiscov., 2010, 9, 589–590; DOI: https://doi.org/10.1038/nrd3226.
I. S. Nizamov, L. A. Al’metkina, G. T. Gabdullina, R. R. Shamilov, A. V. Sofronov, L. E. Nikitina, S. A. Lisovskaya, N. I. Glushko, R. A. Cherkasov, Russ. Chem. Bull., 2012, 61, 2370–2371; DOI: https://doi.org/10.1007/s11172-012-0336-7.
N. O. Ilchenko, D. V. Sudarikov, P. A. Slepukhin, S. A. Rubtsova, A. V. Kutchin, Chemistry Select, 2021, 6, 1710–1714; DOI:https://doi.org/10.1002/slct.202002657.
E. Nazimova, A. Pavlova, O. Mikhalchenko, I. Il’ina, D. Korchagina, T. Tolstikova, N. Salakhutdinov, Med. Chem. Res., 2016, 25, 1369–1383; DOI: https://doi.org/10.1007/s00044-016-1573-3.
I. V. Il’ina, D. V. Korchagina, E. A. Morozova, T. G. Tolstikova, K. P. Volcho, N. F. Salakhutdinov, Russ. Chem. Bull., 2019, 68, 1061–1066; DOI: https://doi.org/10.1007/s11172-019-2520-5.
N. S. Li-Zhulanov, A. V. Pavlova, D. V. Korchagina, Y. V. Gatilov, K. P. Volcho, T. G. Tolstikova, N. F. Salakhutdinov, Chem. Heterocycl. Compd., 2020, 56, 936–941; DOI: https://doi.org/10.1007/s10593-020-02753-x.
T. M. Le, Z. Szakonyi, Chem. Rec., 2021, 21, 1–33; DOI: https://doi.org/10.1002/tcr.202100194.
I. V. Il’ina. D. V. Korchagina, E. A. Morozova, T. G. Tolstikova, K. P. Volcho, N. F. Salakhutdinov, Russ. Chem. Bull., 2022, 71, 2482–2488; DOI: https://doi.org/10.1007/s11172-022-3677-x.
S. Slater, P. B. Lasonkar, S. Haider, M. J. Alqahtani, A. G. Chittiboyina, I. A. Khan, Tetrahedron Lett., 2018, 59, 807–810; DOI: https://doi.org/10.1016/j.tetlet.2018.01.040.
G. Baishya, B. Sarmah, N. Hazarika, Synlett, 2013, 24, 1137–1141; DOI: https://doi.org/10.1055/s-0032-1316915.
B. Sarmah, G. Baishya, R. K. Baruah, RSC Adv., 2014, 4, 22387–22397; DOI: https://doi.org/10.1039/c4ra02124j.
A. Y. Sidorenko, Y. M. Kurban, A. F. Peixoto, N. S. Li-Zhulanov, J. E. Sánchez-Velandia, A. Aho, J. Wärnå, Y. Gu, K. P. Volcho, N. F. Salakhutdinov, D. Yu. Murzin, V. E. Agabekov, Appl. Catal. A, 2023, 649, 11–13; DOI: https://doi.org/10.1016/j.apcata.2022.118967.
A. Sidorenko, A. Kravtsova, I. Il’ina, J. Warna, D. Korchagina, Yu. Gatilov, K. Volcho, N. Salakhutdinov, D. Murzin, V. Agabekov, J. Catal., 2019, 380, 145; DOI: https://doi.org/10.1016/j.jcat.2019.10.015.
M. V. Khvostov, S. A. Borisov, T. G. Tolstikova, A. V. Dushkin, B. D. Tsyrenova, Y. S. Chistyachenko, N. E. Polyakov, G. G. Dultseva, A. A. Onischuk, S. V. An’kov, Eur. J. Drug Metab. Pharmacokinet., 2017, 42, 431–440; DOI: https://doi.org/10.1007/s13318-016-0357-y.
N. B. Eddy, D. J. Leimbach, Pharmacol. Exp. Ther., 1953, 107, 385–393.
S. Bindu, S. Mazumder, U. Bandyopadhyay, Biochem. Pharmacol., 2020, 180, 114147; DOI: https://doi.org/10.1016/j.bcp.2020.114147.
X. Q. Wang, T. Mokhtari, Y. X. Zeng, L. P. Yue, L. Hu, Neural Plast., 2021, 2021, Art. ID 6682275; DOI: https://doi.org/10.1155/2021/6682275.
G. M. Sheldrick, Acta Crystallogr., Sect. C: Struct. Chem., 2015, 71, 3; DOI: https://doi.org/10.1107/S2053229614024218.
Acknowledgements
The authors are grateful to the Chemical Research Center for Collective Use of the Siberian Branch of the Russian Academy of Sciences, for spectral and analytical measurements.
Funding
This study was performed in the framework of State Assignment for the Laboratory of Pharmacological Research, N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch, Russian Academy of Sciences (NIOC SB RAS), No.1021051402785-4-1.4.1, and the State Assignment for the Laboratory of Physiologically Active Compounds, NIOC SB RAS, No. 1021051703312-0-1.4.1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Animal Testing and Ethics
The animals were handled in strict compliance with the legislation of the Russian Federation, provisions of the European Convention for the Protection of Vertebrate Animals used for Experimental or other Scientific Purposes (2010), and the requirements and recommendations of the Guidelines for the Care and Use of Laboratory Animals. The animal experiments were approved by the Ethical Committee of the N. N. Vorozhtsov Federal State Budgetary Institution of Science, Siberian Branch, Russian Academy of Sciences (protocol No. P-04-05.2022-14 of 24.05.2022).
Conflict of Interest
The authors declare no competing interests.
Additional information
Dedicated to the memory of Academician of the Russian Academy of Sciences G. A. Tolstikov (1933–2013).
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, Vol. 72, No. 10, pp. 2430–2438, October, 2023.
Rights and permissions
About this article
Cite this article
Li-Zhulanov, N.S., Kuznetsova, V.A., Gatilov, Y.V. et al. Chiral N-(dialkyloctahydro-2H-chromen-4-yl)acetamides: synthesis and analgesic activity. Russ Chem Bull 72, 2430–2438 (2023). https://doi.org/10.1007/s11172-023-4044-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-023-4044-2